Overview

to Evaluate the Pharmacokinetics(Cmax, Auc) of CJ Imatinib Mesylate Tablet 200mg x 1 Compared With Gleevec Film-coated Tablet 100mg x 2 in Healthy Male Volunteers

Status:
Completed

Trial end date:
2012-06-01

Target enrollment:

Participant gender:

Summary

This study is designed to evaluate the pharmacokinetics of CJ Imatinib mesylate tablet 1 x 200mg compared with Gleevec film-coated tablet 2 x 100mg in healthy male volunteers.

Phase:

Phase 1

Details

Lead Sponsor:

CJ HealthCare Corporation
HK inno.N Corporation

Treatments:

Imatinib Mesylate